Protein tyrosine phosphorylation controls diverse signaling pathways, and disregulated tyrosine kinase activity plays a direct role in human diseases such as cancer. Because activated kinases exert their effects by phosphorylating multiple substrate proteins, it is difficult or impossible to assess experimentally the contribution of a particular substrate to a cellular response or activity. To overcome this problem, we have developed a novel approach termed the "functional interaction trap," in which two proteins are induced to interact in a pairwise fashion through an engineered, highly specific binding interface. We show that the functional interaction trap can be used to direct a modified tyrosine kinase to specifically phosphorylate a single substrate of choice in vivo, permitting analysis of the resulting biological output. This strategy provides a powerful tool for validating the functional significance of tyrosine phosphorylation and other posttranslational modifications identified by proteomic discovery efforts.
Molecular & Cellular Proteomics 2: 1217-1224, 2003.Protein-tyrosine kinases play a central role in cellular signal transduction, regulating many activities of direct relevance to human disease (1). Accordingly, there is a considerable interest in proteomic efforts to profile and identify tyrosine-phosphorylated proteins under various physiological conditions (2-5). Non-receptor tyrosine kinases such as Src bind via their Src homology (SH) 1 3 and SH2 protein-binding domains to a large number of substrates including cytoskeletal proteins, enzymes, and adaptor molecules (6 -9). This stable interaction with substrates is important for the function of these kinases because of the relatively weak enzymatic activity and modest substrate specificity of their catalytic domains (9, 10); nonreceptor tyrosine kinases lacking functional SH2 domains have dramatically reduced activity in vivo (11,12). Src-substrate interaction leads to the phosphorylation of substrate tyrosine residues, thereby affecting a host of important cellular processes such as cell proliferation, adhesion, migration, differentiation, and survival (13,14). Constitutively active Src mutants such as the v-Src gene product of Rous sarcoma virus induce malignant transformation, and activation of Src and other non-receptor tyrosine kinases has been observed in human tumors (15,16).Many substrates of normal and transforming tyrosine kinases have been identified, but in almost all cases the relative contribution of individual substrates to the biological activities elicited by these kinases remains unknown. This is because kinases generally phosphorylate many different substrates upon activation, and no experimental method is currently available to induce phosphorylation of a single substrate of interest in the absence of the simultaneous phosphorylation of others. Because this is a fundamental hurdle to understanding and manipulating tyrosine kinase-mediated signaling pathways, for example in validating targets for drug discovery downstream of...